Scheduled Maintenance
We have scheduled some maintenance on Saturday 4th of May 2024 starting from 10AM CEST and could last for 2 hours. During this maintenance we are expecting our website to be unavailable or not fully functional.
ADIAL PHARMACEUTICALS INC (ADIL)
US00688A2050 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 6.89M | 13.32M | 17.74M | 10.93M | 8.24M | |||
| Research and Development | 1.27M | 4.18M | 8.40M | 5.85M | 3.97M | |||
| Selling, General, and Administrative Expenses | 5.62M | 9.14M | 9.34M | 5.07M | 4.28M | |||
| Operating Income | -6.89M | -13.32M | -17.74M | -10.93M | -8.24M | |||
| Interest Income/Expense | -124.11K | 60.00K | 10.00K | 30.00K | 100.00K | |||
| Other Income/Expense | 10.16K | 520.00K | -260.00K | 0.00 | -440.00K | |||
| Non Recurring Items | N/A | 0.00 | -1.52M | N/A | 0.00 | |||
| Income Before Taxes | -7.00M | -12.73M | -19.52M | -10.89M | -8.59M | |||
| Income Tax | 0.00 | 0.00 | -90.00K | N/A | 0.00 | |||
| Net Income | -5.12M | -12.73M | -19.42M | -10.89M | -8.59M | |||
| EBITDA | -6.89M | -13.31M | -17.73M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.59 | -12.71 | -26.24 | -21.78 | -22.02 | |||
| Non GAAP EPS | -4.32 | -13.00 | N/A | -0.86 | N/A | |||
| Statistics | ||||||||
All data in USD